SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Lupus
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Navarro, M.
Right arrow Articles by Ingelmo, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Navarro, M.
Right arrow Articles by Ingelmo, M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Reviews

Review : Anti-endothelial cell antibodies in systemic autoimmune diseases: prevalence and clinical significance

M. Navarro

Systemic Autoimmune Diseases Unit, Hospital Clinic

R. Cervera

Systemic Autoimmune Diseases Unit, Hospital Clinic

J. Font

Systemic Autoimmune Diseases Unit, Hospital Clinic

JC Reverter

Department of Hemotherapy and Hemostasis, Hospital Clinic, Barcelona, Catalonia, Spain

J. Monteagudo

Department of Hemotherapy and Hemostasis, Hospital Clinic, Barcelona, Catalonia, Spain

G. Escolar

Department of Hemotherapy and Hemostasis, Hospital Clinic, Barcelona, Catalonia, Spain

A. López-Soto

Systemic Autoimmune Diseases Unit, Hospital Clinic

A. Ordinas

Department of Hemotherapy and Hemostasis, Hospital Clinic, Barcelona, Catalonia, Spain

M. Ingelmo

Systemic Autoimmune Diseases Unit, Hospital Clinic

Objective: To investigate the prevalence and characteristics of anti-endothelial cell antibodies (AECA) in a large cohort of patients with several well defined systemic autoimmune diseases, in order to determine their relationship with the clinical and laboratory features of these diseases.

Methods: Clinical and laboratory features of 216 consecutive Caucasian patients were prospectively studied. One hundred and seven patients had been diagnosed as having a primary systemic vasculitis-specifically, 39 had temporal arteritis (TA), 25 polyarteritis nodosa (PAN), 9 Wegener's granulomatosis (WG), and 34 Behçet's disease (BD)-, 90 patients had systemic lupus erythematosus (SLE), and 19 had a primary Sjögren's syndrome (SS). The AECA were determined by ELISA.

Results: One hundred and four (48%) patients with systemic autoimmune diseases were found to have a positive titre of AECA. Specifically, AECA were detected in 41 (38%) patients with a primary systemic vasculitis (13 (33%) with TA, 14 (56%) with PAN, 5 (56%) with WG and 9 (26%) with BD), in 58 (63%) patients with SLE, and in 5 (26%) patients with a primary SS. In patients with a primary systemic vasculitis, those with AECA were found to have an increased prevalence of disease activity (P < 0.05). In SLE patients, those with AECA were found to have an increased prevalence of vascular lesions (P < 0.05), lupus nephropathy (P < 0.05), and antic ardiolipin antibodies (aCL) (P < 0.001).

Conclusions: Patients with systemic autoimmune diseases have a high prevalence of AECA and they are associated with the presence of vascular lesions, nephropathy, and aCL in SLE, as well as with disease activity in several primary systemic vasculitis (TA, PAN, WG and BD).

Key Words: anti-endothelial cell antibodies • systemic vasculitis • systemic lupus erythematosus • antiphospholipid antibodies

Lupus, Vol. 6, No. 6, 521-526 (1997)
DOI: 10.1177/096120339700600608


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
BloodHome page
T. Pham, C. J. Gregg, F. Karp, R. Chow, V. Padler-Karavani, H. Cao, X. Chen, J. L. Witztum, N. M. Varki, and A. Varki
Evidence for a novel human-specific xeno-auto-antibody response against vascular endothelium
Blood, December 10, 2009; 114(25): 5225 - 5235.
[Abstract] [Full Text] [PDF]


Home page
LupusHome page
D. Domiciano, J. Carvalho, and Y. Shoenfeld
Pathogenic role of anti-endothelial cell antibodies in autoimmune rheumatic diseases
Lupus, November 1, 2009; 18(13): 1233 - 1238.
[Abstract] [PDF]


Home page
LupusHome page
E Robak, M Kierstan, B Cebula, A Krawczynska, A Sysa-Jedrzejowska, A Wierzbowska, P Smolewski, and T Robak
Circulating endothelial cells and angiogenic proteins in patients with systemic lupus erythematosus
Lupus, April 1, 2009; 18(4): 332 - 341.
[Abstract] [PDF]


Home page
BloodHome page
P. Margutti, P. Matarrese, F. Conti, T. Colasanti, F. Delunardo, A. Capozzi, T. Garofalo, E. Profumo, R. Rigano, A. Siracusano, et al.
Autoantibodies to the C-terminal subunit of RLIP76 induce oxidative stress and endothelial cell apoptosis in immune-mediated vascular diseases and atherosclerosis
Blood, May 1, 2008; 111(9): 4559 - 4570.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
S. I. van Leuven, R. Franssen, J. J. Kastelein, M. Levi, E. S. G. Stroes, and P. P. Tak
Systemic inflammation as a risk factor for atherothrombosis
Rheumatology, January 1, 2008; 47(1): 3 - 7.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
C Belizna, A Duijvestijn, M Hamidou, and J W Cohen Tervaert
Antiendothelial cell antibodies in vasculitis and connective tissue disease
Ann Rheum Dis, December 1, 2006; 65(12): 1545 - 1550.
[Abstract] [Full Text] [PDF]


Home page
LupusHome page
M McMahon, J Grossman, W Chen, and B H Hahn
Inflammation and the pathogenesis of atherosclerosis in systemic lupus erythematosus
Lupus, November 1, 2006; 15(11_suppl): 59 - 69.
[Abstract] [PDF]


Home page
LupusHome page
J C Amor-Dorado, C Garcia-Porrua, and M A Gonzalez-Gay
Anti-endothelial cell antibodies and biopsyproven temporal arteritis
Lupus, February 1, 2002; 11(2): 134 - 134.
[PDF]


Home page
LupusHome page
N D. Papa, E Raschi, G Moroni, P Panzeri, M O Borghi, C Ponticelli, A Tincani, G Balestrieri, and P L Meroni
Anti-endothelial cell IgG fractions from systemic lupus erythematosus patients bind to human endothelial cells and induce a pro-adhesive and a pro-infiammatory phenotype in vitro
Lupus, July 1, 1999; 8(6): 423 - 429.
[Abstract] [PDF]



Advertisement